Rash Decisions

Topical Steroids (Part 2) - Everything you wanted to know but were too afraid to ask!

Rash Decisions

Show Notes

“Somebody with moderate atopic eczema has nine flares a year, each of those flares, perhaps needing topical steroids for two to five weeks at least. So, they're barely stopping the topical steroids.” Dr George Moncrieff Already you can see how patients can very easily, and unintentionally, be prescribed topical steroids long-term, which they are neither intended for, nor licensed for. The impact of this is discussed in this episode, by your hosts Dr George Moncrieff and Dr Roger Henderson. They will also guide you through incidences where topical steroids can be a cause for concern and how to overcome these. Our learned colleagues will cover: How topical steroids affect the skin, including the impact of their pH on our all-important acid mantle. They then dive deeper below the surface to look at how topical steroids compromise the granular activity in the stratum granulosa and the impact of this on our skin barrier. In addition, they look at how topical steroids can thin the skin along with their potential systemic effects, including suppression of the hypothalamic-pituitary-adrenal axis and the immune system Where you absolutely would not want to be using a topical steroid The impact of long-term topical steroid use and tips on how to prevent this, from a simple patient audit to looking at alternatives How in the short-term, topical steroids might seem to be the most cost-effective option, but in the longer term, how alternative solutions reduce real costs. Thank you to our kind sponsor AproDerm, who provide a comprehensive range of quality emollients designed for the management of dry skin conditions, including eczema, psoriasis and ichthyosis. To simplify the process of finding the most suitable emollient for each patient, they have developed a remarkable solution: the AproDerm Emollient Starter Pack. This pack conveniently combines all four of their emollients in a single prescription, enabling patients to identify their ideal emollient more efficiently, aiding both compliance and adherence. Find out more: https://aproderm.com/aproderm-emollient-starter-pack/ LI: https://www.linkedin.com/company/fontus-health-ltd/ Thank you for listening. We hope you find this podcast interesting and helpful, please leave us a review or email [email protected] with any feedback on this episode or suggestions for what you would like to hear about in future podcasts. The views expressed in this podcast are of Dr George Moncrieff and Dr Roger Henderson and Fontus Health has not influenced, participated, or been involved in the programme, materials, or delivery of educational content.

More from Rash Decisions

Feb 3, 2025

In this episode of Rash Decisions, hosts Dr George Moncrieff and Dr Roger Henderson delve into actinic keratoses (AKs), also known as solar keratoses. With expert insights, they discuss the nature of these common sun-induced lesions, their role as markers of both UV exposure and damage, along with practical approaches to diagnosis. Key Takeaways:

Jan 13, 2025

Your hosts Dr George Moncrieff and Dr Roger Henderson are joined once again by special guest Dr Marina Morgan, Consultant Clinical Microbiologist at the Royal Devon and Exeter Hospital. Together, they explore the fascinating and sometimes alarming world of viral skin infections, covering conditions from glandular fever to tropical viral infections like dengue, chikungunya and Zika, along with the global spread of mpox. Key takeaways:

Dec 12, 2024

Dr Marina Morgan, Consultant Clinical Microbiologist at Royal Devon and Exeter Hospital, is back once again, joining Dr George Moncrieff and Dr Roger Henderson in their deep dive into the world of viral rashes. From Kawasaki disease to Covid-19-related skin issues, the trio explores the complexities of diagnosing and managing these, often misunderstood, conditions. Key Takeaways:

Nov 25, 2024

We’ve gone viral! Join Dr George Moncrieff and Dr Roger Henderson as they discuss paraviral rashes, where the rash is an immune response to the virus. They’ll be covering:

Oct 1, 2024

Dr George Moncrieff and Dr Roger Henderson share their wisdom on viral infections. In the first of three episodes on this topic, they’ll cover cytopathogenic rashes, where the virus is present in the skin lesion. Along with sharing their top six viral facts, they’ll talk you through: Viral warts Herpes simplex infections Chickenpox Shingles Orf Molluscum contagiosum For each of these conditions, they’ll discuss what the virus is up to, share their experiences on the available treatments and complications that you should be aware of in primary care. Thank you to our kind sponsor AproDerm, who provide a comprehensive range of quality emollients designed for the management of dry skin conditions, including eczema, psoriasis and ichthyosis. To simplify the process of finding the most suitable emollient for each patient, they have developed a remarkable solution: the AproDerm Emollient Starter Pack. This pack conveniently combines all four of their emollients in a single prescription, enabling patients to identify their ideal emollient more efficiently, aiding both compliance and adherence. Find out more: https://aproderm.com/aproderm-emollient-starter-pack/ LI: https://www.linkedin.com/company/fontus-health-ltd/ Got some feedback for us? Please rate and review Rash Decisions to help us keep creating educational podcasts for you. Is there a dermatology topic you’d like us to explore? Email us at [email protected], and we’ll do our best to cover it. The views expressed in this podcast are of Dr George Moncrieff and Dr Roger Henderson. Fontus Health has not influenced, participated, or been involved in the programme, materials, or delivery of educational content.

See all episodes →